相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up
Blanche P. Alter et al.
HAEMATOLOGICA (2018)
Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up
Blanche P. Alter et al.
HAEMATOLOGICA (2018)
Outcome of hematopoietic cell transplantation for DNA double-strand break repair disorders
James Slack et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Classical inherited bone marrow failure syndromes with high risk for myelodysplastic syndrome and acute myelogenous leukemia
Sharon A. Savage et al.
SEMINARS IN HEMATOLOGY (2017)
Somatic, hematologic phenotype, long-term outcome, and effect of hematopoietic stem cell transplantation. An analysis of 97 Fanconi anemia patients from the Italian national database on behalf of the Marrow Failure Study Group of the AIEOP (Italian Association of Pediatric Hematology-Oncology)
Johanna Svahn et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Survival after Hematopoietic Stem Cell Transplant in Patients with Dyskeratosis Congenita: Systematic Review of the Literature
Pasquale Barbaro et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
Allogeneic hematopoietic stem cell transplantation for dyskeratosis congenita
Shaimaa Elmahadi et al.
CURRENT OPINION IN HEMATOLOGY (2016)
Danazol Treatment for Telomere Diseases
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Response to androgen therapy in patients with dyskeratosis congenita
Payal P. Khincha et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Dyskeratosis Congenita
Shahinaz M. Gadalla et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience
Regis Peffault de Latour et al.
BLOOD (2013)
Reduced intensity conditioning is effective for hematopoietic SCT in dyskeratosis congenita-related BM failure
M. Ayas et al.
BONE MARROW TRANSPLANTATION (2013)
Haematological recovery in dyskeratosis congenita patients treated with danazol
Amin Islam et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders
Bari J. Ballew et al.
EXPERT REVIEW OF HEMATOLOGY (2013)
Dyskeratosis congenita as a disorder of telomere maintenance
Nya D. Nelson et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2012)
Syndrome complex of bone marrow failure and pulmonary fibrosis predicts germline defects in telomerase
Erin M. Parry et al.
BLOOD (2011)
Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita
A. C. Dietz et al.
BONE MARROW TRANSPLANTATION (2011)
The genetics of dyskeratosis congenita
Philip J. Mason et al.
CANCER GENETICS (2011)
Reduced-Intensity Conditioning Using Fludarabine and Antithymocyte Globulin Alone Allows Stable Engraftment in a Patient with Dyskeratosis Congenita
L. G. Vuong et al.
ACTA HAEMATOLOGICA (2010)
Reduced-Intensity Conditioning Regimen Workshop: Defining the Dose Spectrum. Report of a Workshop Convened by the Center for International Blood and Marrow Transplant Research
Sergio Giralt et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Mechanisms of Disease: Telomere Diseases.
Rodrigo T. Calado et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)